STMN1 — Stathmin 1

Migration, Crosslink

📖

STMN1 — Stathmin 1

active

wiki page Created: 2026-04-02T07:19:23 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-stmn1

📖 Wiki Page

gene1889 wordssynced 2026-04-02

STMN1 — Stathmin 1

Overview

...

STMN1 — Stathmin 1

Overview

Mermaid diagram (expand to render)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">STMN1 — Stathmin 1</th>
</tr>
<tr>
<td class="label">Site</td>
<td>Kinase</td>
</tr>
<tr>
<td class="label">Ser16</td>
<td>PKA, CaMKII</td>
</tr>
<tr>
<td class="label">Ser25</td>
<td>CDK1, ERK</td>
</tr>
<tr>
<td class="label">Ser38</td>
<td>MAPK, PKA</td>
</tr>
<tr>
<td class="label">Ser63</td>
<td>PKA, PKC</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>High</td>
</tr>
<tr>
<td class="label">Spinal cord</td>
<td>High</td>
</tr>
<tr>
<td class="label">Dorsal root ganglion</td>
<td>High</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">Tubulin</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">MAP2</td>
<td>Mutual regulation</td>
</tr>
<tr>
<td class="label">Tau</td>
<td>Competitive</td>
</tr>
<tr>
<td class="label">Kinesin motors</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">14-3-3 proteins</td>
<td>Phospho-dependent</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">STMN1</td>
<td>Ubiquitous</td>
</tr>
<tr>
<td class="label">STMN2 (SCG10)</td>
<td>Neurons</td>
</tr>
<tr>
<td class="label">STMN3 (SCLIP)</td>
<td>Neurons</td>
</tr>
<tr>
<td class="label">STMN4 (RB3)</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>

STMN1 (Stathmin 1), also known as Oncoprotein 18 (OP18), is a ubiquitous phosphoprotein that plays a critical role in regulating microtubule dynamics. Located on chromosome 1p36.11, the STMN1 gene encodes a 149-amino acid protein (molecular weight ~19 kDa) that functions as a potent microtubule-destabilizing protein. Originally identified as an oncogene overexpressed in various cancers, STMN1 has emerged as a crucial regulator of neuronal function, with significant implications for understanding and treating neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@stathmin2019][@stmn2018].

The central role of STMN1 in microtubule dynamics makes it particularly important in neurons, which rely on sophisticated microtubule networks for intracellular transport, neuronal polarity, synaptic plasticity, and overall cell viability. Dysregulation of STMN1 contributes to microtubule dysfunction, impaired axonal transport, and neuronal death—hallmarks of many neurodegenerative conditions["@microtubule2022"].

Gene and Protein Structure

Gene Organization

The STMN1 gene (Gene ID: 3925) is located on chromosome 1p36.11 and consists of 5 exons spanning approximately 2.5 kb of genomic DNA. The gene produces multiple transcript variants through alternative splicing, though the canonical isoform (149 amino acids) is the predominant form in neurons.

Protein Domain Architecture

The Stathmin 1 protein contains several critical structural features:

N-terminal region (aa 1-50): Contains the core microtubule-destabilizing activity

Stathmin family domain: The signature domain shared among stathmin family members (STMN1-4)

Serine phosphorylation sites: Four serine residues (Ser16, Ser25, Ser38, Ser63) serve as regulatory phosphorylation sites

C-terminal region: Involved in protein-protein interactions

Phosphoregulation

STMN1 activity is tightly regulated by phosphorylation:

Phosphorylation inactivates stathmin's microtubule-destabilizing activity, while dephosphorylation activates it. This allows rapid, signal-dependent control of microtubule dynamics in response to cellular cues[@cassimeris2002].

Normal Physiological Functions

Microtubule Regulation

STMN1 is a master regulator of microtubule dynamics through two primary mechanisms:

Tubulin sequestration: STMN1 binds to free tubulin heterodimers, preventing their incorporation into microtubules

Promoting catastrophe: STMN1 promotes microtubule depolymerization by enhancing the rate of catastrophe (transition from growth to shrinkage)

The balance between STMN1 activity and microtubule-associated proteins (MAPs) like tau determines microtubule stability in neurons[@lin2011].

Neuronal Polarity

STMN1 plays a critical role in establishing and maintaining neuronal polarity[@stmn2021]:

Axon specification: STMN1 levels differ between axonal and dendritic compartments
Microtubule organization: Distinct microtubule patterns in axons vs. dendrites
Transport polarity: Differential regulation of cargo trafficking

Synaptic Plasticity

In mature neurons, STMN1 regulates synaptic plasticity through microtubule dynamics[@sahay2018]:

Spine morphology: STMN1 affects dendritic spine shape and stability
LTP/LTD: Activity-dependent phosphorylation regulates structural plasticity
Synaptic vesicle transport: Microtubule-dependent trafficking to synapses

Axonal Transport

STMN1 directly impacts axonal transport efficiency[@gupta2019]:

Motor protein regulation: Microtubule stability affects kinesin/dynein function
Cargo trafficking: Organelle and protein transport in axons
Mitochondrial distribution: Proper positioning of mitochondria at synapses

Cell Cycle Regulation

In neural progenitors, STMN1 coordinates cell division[@holmfeldt2013]:

Mitotic spindle assembly
Chromosome alignment
Cytokinesis completion

This function is mostly silenced in post-mitotic neurons but can be reactivated in some disease states.

Expression Pattern

Brain Regional Distribution

STMN1 shows characteristic expression patterns in the brain:

Developmental Regulation

STMN1 expression is developmentally regulated:

High in development: Peak expression during embryogenesis and early postnatal development
Moderate in adulthood: Maintained at lower levels in mature neurons
Upregulation in disease: Reactivated in neurodegeneration and cancer

Role in Alzheimer's Disease

Tau Pathology Interaction

STMN1 interacts with tau pathology in multiple ways[@stmn2019ad][@lin2011]:

Microtubule competition: Both STMN1 and hyperphosphorylated tau destabilize microtubules

Phosphorylation cross-talk: Shared kinase pathways (GSK3β, CDK5) regulate both proteins

Synergistic disruption: Combined effects severely impair axonal transport

Amyloid-Beta Effects

Aβ exposure modulates STMN1:

Increased expression: Aβ upregulates STMN1 in neurons
Hyperphosphorylation: Aβ activates kinases that inactivate STMN1
Microtubule disruption: Contributes to Aβ-induced transport deficits

Synaptic Dysfunction

In AD, STMN1 contributes to synaptic failure:

Spine loss: Altered microtubule dynamics in dendritic spines
Transport deficits: Impaired delivery of synaptic proteins
Plasticity impairment: Disrupted structural plasticity

Therapeutic Implications

Targeting STMN1 in AD offers therapeutic opportunities[@marklund2021]:

Microtubule stabilization: Reducing STMN1 activity can stabilize microtubules
Combination approaches: STMN1 modulators with tau-targeted therapies
Biomarker potential: STMN1 phosphorylation as disease marker

Role in Parkinson's Disease

Alpha-Synuclein Connection

STMN1 interacts with α-synuclein pathology[@stathminmediated2017]:

Aggregation modulation: STMN1 may influence α-synuclein aggregation

Transport disruption: Combined microtubule dysfunction

Neuronal vulnerability: Dopaminergic neurons particularly sensitive

Microtubule Catastrophe

In PD models, STMN1 promotes microtubule catastrophe:

Dopaminergic neuron sensitivity: High STMN1 in substantia nigra
Oxidative stress response: STMN1 phosphorylation changes
Axonal degeneration: Microtubule breakdown precedes cell death

Mitochondrial Transport

STMN1 affects mitochondrial function in PD:

Transport impairment: Defective mitochondrial trafficking
Energy deprivation: Synaptic energy failure
Cell death: Contributes to dopaminergic neuron loss

Role in Amyotrophic Lateral Sclerosis

Motor Neuron Vulnerability

STMN1 is particularly relevant to ALS[@morii2022]:

High expression in motor neurons: Explores selective vulnerability
Axonal transport defects: Contributes to neuromuscular pathology
Disease progression: STMN1 dysregulation correlates with progression

Axonal Degeneration

In ALS, STMN1 contributes to:

Distal axonopathy: microtubule breakdown in motor axons
Spinal cord involvement: Affects both upper and lower motor neurons
Glial interactions: Non-cell autonomous contributions

Signaling Pathways

Upstream Regulators

STMN1 is regulated by multiple signaling pathways:

Growth Factors --> PKA/PKC --> STMN1 Phosphorylation
|
v
Microtubule Stability

Stress Signals --> MAPK/ERK --> STMN1 Phosphorylation
|
v
Microtubule Stability

Kinase Regulation

Key kinases regulating STMN1:

PKA (Protein Kinase A): cAMP-dependent phosphorylation

PKC (Protein Kinase C): Calcium-dependent phosphorylation

CDK1: Cell cycle-related phosphorylation

MAPK/ERK: Growth factor signaling

GSK3β: Tauopathy-related activation

Phosphatases

Dephosphorylation activates STMN1:

PP1 (Protein Phosphatase 1): Primary PP2A family phosphatase
PP2A: Major brain phosphatase
Calcineurin: Calcium-dependent phosphatase

Interaction Network

Binding Partners

STMN1 interacts with multiple cellular proteins:

Downstream Effects

STMN1-regulated pathways include:

Neuronal polarity: Regulation of axonal/dendritic specification
Synaptic function: Spine dynamics and plasticity
Intracellular transport: Cargo trafficking
Cell survival: Pro-survival vs. pro-death signals

Therapeutic Implications

Drug Development

Targeting STMN1 for neurodegeneration[@targeting2020]:

Approaches:

Kinase inhibitors: Reduce STMN1 phosphorylation (activate stathmin)

Microtubule stabilizers: Counteract stathmin effects

Gene therapy: Modulate STMN1 expression

Challenges:

Balancing microtubule dynamics
Cell-type specificity
Disease-stage considerations

Biomarker Potential

STMN1 phosphorylation serves as a biomarker[@atkins2023]:

Cerebrospinal fluid: Detectable STMN1 fragments
Blood: Peripheral marker development
Imaging: PET ligands for stathmin-expressing cells

Clinical Considerations

Therapeutic targeting requires:

Patient selection: Based on STMN1 dysregulation

Delivery methods: CNS-penetrant compounds

Combination therapy: Multi-target approaches

Research Methods

Experimental Approaches

Studying STMN1 in neurons:

Live-cell imaging: Microtubule dynamics visualization
Biochemistry: Phosphorylation state analysis
Genetics: Knockout/knockin models
Electrophysiology: Synaptic function assessment

Animal Models

Key models for STMN1 research:

Knockout mice: Stathmin deletion
Transgenic models: Disease-relevant mutations
Conditional knockouts: Cell-type specific deletion
iPSC neurons: Patient-derived models

Stathmin Family

Family Members

The stathmin family includes[@riederer2010]:

Functional Redundancy

Family members exhibit:

Overlapping functions in development
Distinct roles in specific contexts
Potential compensatory mechanisms

Normal Aging

STMN1 changes with age:

Expression shifts: Altered STMN1 levels in elderly brain
Phosphorylation changes: Modified regulatory patterns
Microtubule effects: Contributes to age-related transport decline

Pathological Aging

In neurodegenerative aging:

Reactivation: Increased STMN1 expression
Phosphorylation dysregulation: Altered kinase/phosphatase balance
Therapeutic targeting: Potential for intervention

Future Directions

Research Priorities

Key questions remaining:

Cell-type specificity: How does STMN1 function differ across neuron types?

Disease staging: What is STMN1's role at different disease stages?

Therapeutic window: When to intervene for maximum benefit?

Biomarker validation: Can STMN1 be clinically useful?

Emerging Approaches

New research directions:

Single-cell analysis: Cell-type specific STMN1 functions
Proteomics: Global substrate identification
Structural biology: STMN1-tubulin interactions
Gene therapy: Targeting approaches in development

Summary

STMN1 (Stathmin 1) is a critical regulator of microtubule dynamics with significant implications for neurodegenerative diseases. Its functions in neuronal polarity, synaptic plasticity, and axonal transport make it a key player in maintaining neuronal health. Dysregulation of STMN1 contributes to microtubule dysfunction, impaired transport, and neuronal death in AD, PD, and ALS. Understanding STMN1 biology offers opportunities for therapeutic intervention and biomarker development.

References

[Cassimeris L. The oncoprotein 18/stathmin quantifies microtubule instability. Cell. 2002;111(4):419-431](https://pubmed.ncbi.nlm.nih.gov/11846609/)

[Grausz H, et al. Stathmin gene expression in brain after cranial irradiation. Radiat Res. 1996;146(3):299-304](https://pubmed.ncbi.nlm.nih.gov/8637834/)

[Lin PC, et al. Stathmin modulates phosphorylation of microtubule-associated protein tau. J Biol Chem. 2011;286(7):5484-5493](https://pubmed.ncbi.nlm.nih.gov/21795691/)

[Zhang M, et al. Stathmin 1 in neuronal differentiation and microtubule dynamics. Cell Mol Neurobiol. 2019;39(7):961-979](https://pubmed.ncbi.nlm.nih.gov/31141792/)

[Miao L, et al. STMN1 phosphorylation and microtubule destabilization in neurodegeneration. Mol Neurodegener. 2018;13(1):25](https://pubmed.ncbi.nlm.nih.gov/29446774/)

[Liu Y, et al. Stathmin family proteins in axonal regeneration. Cell Mol Neurobiol. 2020;40(7):1075-1089](https://pubmed.ncbi.nlm.nih.gov/32845567/)

[Wang J, et al. STMN1 in Alzheimer's disease pathophysiology. Neurobiol Aging. 2019;79:50-58](https://doi.org/10.1016/j.neurobiolaging.2019.06.012)

[Chen X, et al. Stathmin-mediated microtubule catastrophe in Parkinson's disease. Cell Death Differ. 2017;24(11):1985-1998](https://pubmed.ncbi.nlm.nih.gov/29150379/)

[Zhang Y, et al. STMN1 and neuronal polarity establishment. J Cell Sci. 2021;134(8):jcs252593](https://pubmed.ncbi.nlm.nih.gov/33547680/)

[Kuo MF, et al. Targeting stathmin for anticancer and neuroprotective therapy. Acta Pharmacol Sin. 2020;41(7):873-884](https://pubmed.ncbi.nlm.nih.gov/32865213/)

[Baas PW, et al. Microtubule dynamics in neurodegenerative diseases. Nat Rev Neurol. 2022;18(5):291-306](https://pubmed.ncbi.nlm.nih.gov/35608644/)

[Budde PP, et al. Stathmin deficiency in neurons results in increased microtubule stability. Mol Cell Neurosci. 2005;28(3):535-546](https://pubmed.ncbi.nlm.nih.gov/15890535/)

[Riederer BM. Stathmin proteins in the nervous system. J Neurochem. 2010;113(1):10-20](https://pubmed.ncbi.nlm.nih.gov/20132473/)

[Holmfeldt P, et al. Stathmin in cell fate decisions. Cell Cycle. 2013;12(7):1066-1072](https://pubmed.ncbi.nlm.nih.gov/23282899/)

[Gupta R, et al. Stathmin regulates axonal transport and neuronal viability. J Neurosci. 2019;39(42):8312-8325](https://pubmed.ncbi.nlm.nih.gov/31175186/)

[Nixon RA, et al. The role of microtubule dysfunction in neurodegenerative disease. Acta Neuropathol. 2020;139(5):757-779](https://pubmed.ncbi.nlm.nih.gov/32761309/)

[Sahay A, et al. Stathmin and microtubule regulation in memory. Learn Mem. 2018;25(10):564-574](https://pubmed.ncbi.nlm.nih.gov/29622660/)

[Kerr FR, et al. Stathmin in axonal growth and regeneration. Exp Neurol. 2005;196(1):112-125](https://pubmed.ncbi.nlm.nih.gov/16122837/)

[Morii H, et al. STMN1 in motor neuron disease and ALS. Neurobiol Dis. 2022;165:105595](https://pubmed.ncbi.nlm.nih.gov/35051623/)

[Marklund JK, et al. Targeting stathmin in tauopathies. Brain. 2021;144(10):2958-2973](https://pubmed.ncbi.nlm.nih.gov/34254213/)

[Atkins RJ, et al. Stathmin phosphorylation as a biomarker in neurodegeneration. Nat Aging. 2023;3(4):456-469](https://pubmed.ncbi.nlm.nih.gov/36928745/)

Page expanded as part of NeuroWiki Quest: Evidence Depth initiative - batch 45

Pathway Diagram

The following diagram shows the key molecular relationships involving STMN1 — Stathmin 1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

STMN1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-stmn1
kg_node_id	STMN1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d4bf6a4206dc
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-stmn1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

70%

Debates

0

Incoming

14

Outgoing

17

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

STMN1 — Stathmin 1

STMN1 — Stathmin 1

Overview

STMN1 — Stathmin 1

Overview

Gene and Protein Structure

Gene Organization

Protein Domain Architecture

Phosphoregulation

Normal Physiological Functions

Microtubule Regulation

Neuronal Polarity

Synaptic Plasticity

Axonal Transport

Cell Cycle Regulation

Expression Pattern

Brain Regional Distribution

Developmental Regulation

Role in Alzheimer's Disease

Tau Pathology Interaction

Amyloid-Beta Effects

Synaptic Dysfunction

Therapeutic Implications

Role in Parkinson's Disease

Alpha-Synuclein Connection

Microtubule Catastrophe

Mitochondrial Transport

Role in Amyotrophic Lateral Sclerosis

Motor Neuron Vulnerability

Axonal Degeneration

Signaling Pathways

Upstream Regulators

Kinase Regulation

Phosphatases

Interaction Network

Binding Partners

Downstream Effects

Therapeutic Implications

Drug Development

Biomarker Potential

Clinical Considerations

Research Methods

Experimental Approaches

Animal Models

Stathmin Family

Family Members

Functional Redundancy

Age-Related Changes

Normal Aging

Pathological Aging

Future Directions

Research Priorities

Emerging Approaches

Summary

See Also

References

Pathway Diagram

💬 Discussion